Trials / Completed
CompletedNCT03629236
Study to Evaluate Safety and Efficacy of GrafixPL for the Treatment of Venous Leg Ulcers
A Multicenter, Prospective, Randomized, Open-Label Study With a Crossover Extension Option to Evaluate the Safety and Efficacy of GrafixPL for the Treatment of Chronic Venous Leg Ulcers
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Osiris Therapeutics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A Multicenter, Prospective, Randomized, Open-Label Study with a Crossover Extension Option to Evaluate the Safety and Efficacy of GrafixPL for the Treatment of Chronic VLUs
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | GrafixPL | Debridement, GrafixPL application, dressing application, standard compression therapy |
| OTHER | Control | Debridement, dressing application, standard compression therapy |
Timeline
- Start date
- 2018-06-27
- Primary completion
- 2021-06-24
- Completion
- 2021-06-24
- First posted
- 2018-08-14
- Last updated
- 2022-04-12
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03629236. Inclusion in this directory is not an endorsement.